Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

[1]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[2]  S. Yusuf,et al.  A lifetime of prevention: the case of heart failure. , 2002, Circulation.

[3]  N. Freemantle,et al.  Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey , 2002, The Lancet.

[4]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[5]  Simon Stewart,et al.  Home-Based Intervention in Congestive Heart Failure: Long-Term Implications on Readmission and Survival , 2002, Circulation.

[6]  L. Erhardt,et al.  The management of heart failure in Sweden , 2002, European journal of heart failure.

[7]  K. Swedberg,et al.  Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.

[8]  L. Wilhelmsen,et al.  Heart failure in the general population of men--morbidity, risk factors and prognosis. , 2001, Journal of internal medicine.

[9]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? , 2001, European heart journal.

[10]  J. Pell,et al.  Evidence of Improving Prognosis in Heart Failure: Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 , 2000, Circulation.

[11]  J. Marrugat,et al.  The management of heart failure in Sweden , 2000, European journal of heart failure.

[12]  L. Alfredsson,et al.  Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987–95. Results from the National AMI Register in Sweden , 2000, Journal of internal medicine.

[13]  A. Dobson,et al.  Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations , 2000, The Lancet.

[14]  L. Wilhelmsen,et al.  Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943 , 2000, Journal of internal medicine.

[15]  F. Andersson,et al.  The health care costs of heart failure in Sweden , 1999, Journal of internal medicine.

[16]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[17]  D. Levy,et al.  Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. , 1999, The New England journal of medicine.

[18]  V. Salomaa,et al.  Decreasing Mortality from Acute Myocardial Infarction: Effect of Incidence and Prognosis , 1999, Journal of cardiovascular risk.

[19]  J. Croft,et al.  Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. , 1999, American heart journal.

[20]  K. Bailey,et al.  Congestive heart failure in the community: trends in incidence and survival in a 10-year period. , 1999, Archives of internal medicine.

[21]  J. McMurray.  Major beta blocker mortality trials in chronic heart failure: a critical review. , 1999, Heart.

[22]  J. McMurray,et al.  Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. , 1998, European heart journal.

[23]  L. Wilhelmsen,et al.  Improved long-term prognosis after myocardial infarction 1984-1991. , 1998, European heart journal.

[24]  M. Rich,et al.  CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults , 1997, Journal of the American Geriatrics Society.

[25]  C. Mulrow,et al.  Can the clinical examination diagnose left-sided heart failure in adults? , 1997, JAMA.

[26]  R F Anda,et al.  National Trends in the Initial Hospitalization for Heart Failure , 1997, Journal of the American Geriatrics Society.

[27]  K Harley,et al.  Quality of Scottish Morbidity Record (SMR) data. , 1996, Health bulletin.

[28]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[29]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[30]  S. Yusuf,et al.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. , 1995, JAMA.

[31]  H. Eriksson.  Heart failure: a growing public health problem , 1995, Journal of internal medicine.

[32]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[33]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[34]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[35]  L. Wilhelmsen,et al.  Epidemiology and prognosis of heart failure. , 1991, Zeitschrift fur Kardiologie.

[36]  Lichtlen Pr,et al.  [rt-PA versus streptokinase--Has the controversy regarding the optimal thrombolytic agent been resolved by results of the GISSI II/International rt-PA vs. Streptokinase fatality Study?]. , 1991 .

[37]  R. Cooper,et al.  Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. , 1990, Archives of internal medicine.

[38]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[39]  A. Morrison,et al.  The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. , 1982, International journal of epidemiology.

[40]  K. Swedberg,et al.  PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.